Page last updated: 2024-08-25

methotrexate and Granulocytic Leukemia, Chronic

methotrexate has been researched along with Granulocytic Leukemia, Chronic in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (6.67)	18.7374
1990's	45 (50.00)	18.2507
2000's	28 (31.11)	29.6817
2010's	11 (12.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barth, TFE; Dugge, R; Erlemann, R; Kreipe, H; Lehmann, U; Möller, P; Rosenwald, A	1
Dağlı, M; Keles Oğlu, KS; Koplay, M; Paksoy, Y; Sivri, M	1
Abruzzo, L; Borthakur, G; Cortes, J; Faderl, S; Jabbour, E; Jorgensen, JL; Kantarjian, H; Konoplev, S; Luthra, R; O'Brien, S; Quintas-Cardama, A; Ravandi, F; Strati, P; Thomas, D	1
Adachi, S; Atsuta, Y; Azuma, E; Chin, M; Goto, H; Hatakeyama, N; Hyakuna, N; Igarashi, S; Inoue, M; Kato, K; Koh, K; Kudo, K; Murata, M; Ogawa, A; Ohshima, K; Sakata, N; Sawada, A; Takahashi, Y; Takami, A; Tanaka, S; Umeda, K	1
Audemard, A; Bergot, E; Chantepie, S; de la Gastine, B; Gac, AC; Reman, O; Verger, H	1
Cachia, D; Chi, L; Cortes, JE; Daver, N; Kamiya-Matsuoka, C; Kantarjian, HM; Pinnix, CC; Woodman, K	1
Abu Zaid, M; Antin, JH; Choi, SW; Cutler, C; Logan, BR; Paczesny, S; Wu, C; Wu, J; Yu, J	1
Ohno, R	1
Lee, JW; Lee, MH; Park, MY	1
Bauer, K; Engert, A; Kluge, S; Kreuzer, KA; Monsef, I; Siebert, H; Skoetz, N	1
Cai, Z; Han, X; He, J; Huang, H; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhao, Y; Zheng, Y	1
Gao, YQ; Sun, RJ; Sun, Y; Wei, ZJ; Xiao, J; Zhang, YC; Zhu, HL	1
Chen, L; Ding, X; Hou, J; Li, H; Lou, J; Min, B; Song, X; Tong, S; Wang, J; Zhang, W	1
Aricò, M; Basso, G; Biondi, A; Cazzaniga, G; Di Martino, D; Lanciotti, M; Masera, G; Micalizzi, C; Rossi, V; Valsecchi, MG	1
Ashihara, E; Fuchida, S; Fujita, N; Inaba, T; Maruya, E; Nakagawa, M; Ochiai, N; Okano, A; Shimazaki, C; Sumikuma, T	1
Brandwein, J; Gupta, V; Kamel-Reid, S; Lipton, JH; Messner, HA; Minden, MD	1
Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T	1
Chen, Y; Han, W; Hong, H; Huang, X; Lu, D	1
Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Ottmann, OG; Sato, K; Segawa, H; Yuasa, T	1
Bujassoum, S; Lipton, JH; Rifkind, J	1
Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M	1
Raghunadharao, D; Rajappa, S; Rao, IS; Surath, A; Uppin, SG	1
Chen, H; Chen, YH; Han, W; Huang, XJ; Jiang, Q; Liu, DH; Liu, KY; Lu, DP; Xu, LP; Zhang, YC	1
Martin, P; Potter, JD; Robien, K; Schubert, MM; Storb, R; Ulrich, CM; Yasui, Y	1
Adamczyk-Cioch, M; Dmoszyńska, A; Haus, O; Hołowiecki, J; Jakubas, B; Jedrzejczak, WW; Konopka, L; Kuliczkowski, K; Mazur, G; Nowak, K; Paluszewska, M; Pałynyczko, G; Pluta, A; Robak, T; Skotnicki, A; Wawrzyniak, E; Wierzbowska, A; Wrzesień-Kuś, A; Zwolińska, M	1
Leporrier, M; Marcelli, C; Mittre, H	1
Altintas, A; Ayyildiz, O; Cil, T; Kaplan, MA; Kilinc, I	1
Jiang, ZX; Liu, LX; Sun, H; Sun, L; Wan, DM; Xie, XS	1
Arai, S; Asai, T; Chiba, S; Hangaishi, A; Hosoya, N; Izutsu, K; Kanda, Y; Kurokawa, M; Motokura, T; Nakasone, H; Nishimoto, N; Oshima, K; Sato, H; Watanabe, T	1
Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J	1
Gimsing, P; Hippe, E	1
Aschan, J; Ringdén, O	1
Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS	1
Ambrosetti, A; Aprili, F; Krampera, M; Martinelli, G; Meneghini, V; Perona, G; Pizzolo, G; Veneri, D	1
Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Polchi, P; Rapa, S; Ripalti, M	1
Arcese, W; Bandini, G; Bosi, A; Carreras, E; Frassoni, F; Gahrton, G; Gratwohl, A; Hermans, J; Niederwieser, D; Vernant, JP	1
Advani, SH; Ashokkumar, MS; Dhabhar, B; Dhond, SR; Gopal, R; Iyer, RS; Nadkarni, KS; Nair, CN; Nanjangud, G; Saikia, TK	1
Aschan, J; Klaesson, S; Ljungman, P; Lönnqvist, B; Ringdén, O; Sundberg, B	1
Goldman, J; Morleda, J; Mughal, T	1
Babacan, E; Bökesoy, I; Cavdar, AO; Gözdaşoğlu, S; Pamĭr, A; Sunguroğlu, A; Tanindi, S; Türker, A; Unal, E; Yavuz, G	1
Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A	1
Biggs, JC; Champlin, RE; Deeg, HJ; Dicke, K; Gale, RP; Horowitz, MM; Masaoka, T; Powles, RL; Ringdén, O; Sondel, P	1
Black, AR; Dolnick, BJ	1
Arseniev, L; Bähre, O; Diedrich, H; Kadar, JG; Link, H; Poliwoda, H	1
Bartram, CR; Borkhardt, A; Harbott, J; Janka-Schaub, G; Janssen, JW; Kabisch, H; Lampert, F; Ludwig, WD; Ratei, R; Reinisch, I; Repp, R; Riehm, H; Ritterbach, J; Schlieben, S; Schrappe, M; Zimmermann, M	1
Kobayashi, H; Sekiguchi, S; Takemura, Y	1
Dubin Kerr, L; Isola, L; Troy, K	1
Capria, S; Mandelli, F; Meloni, G; Modena, V; Vignetti, M	1
De'Arce, M; Gardiner, N; Lawler, M; McCann, SR; O'Riordan, J	1
Griffin, JD; McIvor, RS; Verfaillie, CM; Zhao, RC	1
Asano, S; Kikuchi, A; Nishikawa, T; Okamoto, S; Takahashi, S	1
Amill, B; Berlanga, JJ; Boqué, C; Brunet, S; Canals, C; Cancelas, JA; Domingo-Albós, A; Ferra, C; Gallardo, D; García-López, J; Grañena, A; Martín-Henao, G; Martínez, C; Martino, R; Picón, M; Sureda, A; Torrico, C	1
Kobayashi, H; Ohnuma, T; Takemura, Y	1
Brice, P; Brison, O; Cojean, I; Devergie, A; Gaulard, P; Gluckman, E; Janin, A; Meignin, V; Parquet, N; Ribaud, P; Socie, G	1
Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R	1
Castagné, C; Jotterand, M; Martinet, D; Mühlematter, D	1
Chiba, S; Hirai, H; Honda, H; Kanda, Y; Yazaki, Y	1
Aschan, J; Carlens, S; Fredrikson, S; Hägglund, H; Hentschke, P; Ljungman, P; Lönnqvist, B; Mattsson, J; Ringdén, O	1
Biggs, JC; Gale, RP; Giralt, S; Goldman, JM; Herzig, RH; Horowitz, MM; Klein, JP; McGlave, PB; Rowlings, PA; Schiller, G; Szydlo, R; Veum-Stone, J	1
Amylon, MD; Bluzme, KG; Chao, NJ; Forman, SJ; Fung, H; Hu, WW; Jain, M; Johnston, LJ; Kashyap, A; Kohler, S; Krishnan, A; Long, GD; Molina, A; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, P; Rodriguez, R; Snyder, DS; Spielberger, R; Stein, A; Stockerl-Goldstein, KE; Tierney, DK; Wong, RM	1
Akutsu, M; Furukawa, Y; Honma, Y; Kano, Y; Mano, H; Sato, Y; Tsunoda, S	1
Durrant, S; Irving, I; Mollee, P; Morton, AJ	1
Jahagirdar, BN; Miller, JS; Shet, A; Verfaillie, CM	1
Ariail, KS; Bigler, J; Farin, FM; Keener, CL; Li, S; Liu, H; Potter, JD; Schubert, MM; Storb, R; Ulrich, CM; Wagner, JL; Yasui, Y	1
Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A	1
Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B	1
Diers, MD; Frandsen, JL; Gunther, R; McIvor, RS; Sweeney, CL; Verfaillie, CM	1
Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R	1
Jastrzebska, M; Lukowska, K; Pacholska, J; Paciorkiewicz, W; Rokicka-Milewska, R	1
Apperley, J; Barrett, AJ; Cullis, JO; Hows, JM; Hughes, TP; Kelly, S; Mackinnon, S; Marks, DI; Schwarer, AP; Szydlo, R	1
Beelen, DW; Brandt, H; Graeven, U; Haralambie, E; Linzenmeier, G; Mahmoud, HK; Müller, KD; Quabeck, K; Sayer, HG; Schaefer, UW	1
Cámara, R; Fernández-Villalta, MJ; Ferro, T; Figuera, A; Kassack, JJ; Lamana, M; López, J; Serrano, F; Steegmann, JL; Vázquez, L	1
Goldman, JM	1
Essell, JH; Halvorson, RD; Harman, GS; Johnson, RA; Rubinsak, JR; Snyder, MJ; Thompson, JM	1
Bogdanić, V; Grgić-Markulin, L; Jakić-Razumović, J; Kalenić, S; Labar, B; Mrsić, M; Nemet, D; Presecki, V; Vrtar, M; Vujasinović, S	1
Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Deeg, HJ; Doney, K; Hansen, J; Pepe, M; Storb, R	1
Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A	1
Maca, RD	1
Hidaka, S; Hiraoka, A; Kobayashi, M; Matsunashi, T; Nakamura, H; Tejima, H; Tominaga, N; Yoshida, H; Yoshida, S; Yoshimura, M	1
Asano, S; Inoue, T; Ogura, H; Ozawa, K; Tani, K; Tojo, A	1
Bacigalupo, A; Corvò, R; Frassoni, F; Gualandi, F; Lamparelli, T; Occhini, D; Scarpati, D; Sessarego, M; Van Lint, MT; Vitale, V	1
Appelbaum, FR; Buckner, CD; Clift, RA; Hansen, JA; Petersen, FB; Sanders, JE; Storb, R; Thomas, ED	1
Bolanowska, WE; Freitag, CM; Jones, CS; Kalman, TI; McGuire, JJ; Russell, CA	1
Ash, R; Beatty, P; Hows, JM; McGlave, PB	1
Koizumi, S	1
Huismans, DR; Leyva, A; Pieters, R; Veerman, AJ	1
Dopfer, R; Ehninger, G; Einsele, H; Grosse-Wilde, H; Haen, M; Jaschonek, KG; Pawelec, G; Rutayungwa, ET; Schmidt, H; Schneider, W	1
Deeg, HJ; McGuire, TR; Self, SG; St Pierre, BA; Sullivan, KM; Yee, GC; Zager, RA	1
Maruyama, Y; Nagata, K; Nakamura, S; Onozawa, Y; Sakamaki, H; Yahara, Y	1
Santos, GW	1

Reviews

8 review(s) available for methotrexate and Granulocytic Leukemia, Chronic

Article	Year
Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy. Current hematologic malignancy reports, 2006, Volume: 1, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Multicenter Studies as Topic; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Remission Induction; Survival Rate; Vincristine	2006
Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia. Transplantation, 1998, Feb-27, Volume: 65, Issue:4 Topics: Adult; Bone Marrow Transplantation; Cyclophosphamide; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mediastinal Neoplasms; Methotrexate; Neoplasms, Second Primary; Tissue Donors; Tumor Virus Infections; Whole-Body Irradiation	1998
Long-term third chronic phase of chronic myelogenous leukemia maintained by interferon-alpha and methotrexate. Leukemia & lymphoma, 1999, Volume: 33, Issue:1-2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Etoposide; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Methotrexate; Mitoxantrone; Remission Induction; Time; Treatment Outcome	1999
Novel therapies for chronic myelogenous leukemia. Experimental hematology, 2001, Volume: 29, Issue:5 Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Benzamides; Cancer Vaccines; Cell Transformation, Neoplastic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Neoplasm; Enzyme Inhibitors; Farnesyltranstransferase; Fusion Proteins, bcr-abl; Genes, myb; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Immunotherapy, Adoptive; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Models, Biological; Multicenter Studies as Topic; Neoplasm Proteins; Oligonucleotides, Antisense; Phosphorylation; Piperazines; Protein Processing, Post-Translational; Pyrimidines; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tetrahydrofolate Dehydrogenase	2001
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone marrow transplantation, 2001, Volume: 28, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation	2001
Bone marrow transplantation for chronic myeloid leukaemia. Leukemia, 1992, Volume: 6 Suppl 2 Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Methotrexate; Recurrence; Time Factors; Transplantation, Homologous	1992
[Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11 Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisolone; Remission Induction	1989
Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia. Cancer detection and prevention, 1988, Volume: 12, Issue:1-6 Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Transplantation Immunology; Virus Diseases	1988

Trials

19 trial(s) available for methotrexate and Granulocytic Leukemia, Chronic

Article	Year
Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT. Blood, 2017, 01-12, Volume: 129, Issue:2 Topics: Adolescent; Adult; Allografts; Area Under Curve; Biomarkers, Tumor; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; ROC Curve; Sensitivity and Specificity; Sirolimus; Tacrolimus; Transplantation, Homologous; Young Adult	2017
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study. Bone marrow transplantation, 2004, Volume: 34, Issue:7 Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors	2004
[Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases]. Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:4 Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Transplantation, Homologous; Young Adult	2007
Combined transplantation of allogeneic bone marrow and CD34+ blood cells. Blood, 1995, Oct-01, Volume: 86, Issue:7 Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation	1995
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. Blood, 1994, Sep-01, Volume: 84, Issue:5 Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation	1994
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide. Bone marrow transplantation, 1994, Volume: 13, Issue:2 Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Prednisolone; Transplantation, Homologous	1994
Transplantation of allogeneic CD34+ blood cells. Blood, 1996, Jun-01, Volume: 87, Issue:11 Topics: Acute Disease; Adult; Antigens, CD34; Bone Marrow; Cell Division; Cyclosporine; Erythropoietin; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; T-Lymphocytes; Transplantation, Homologous	1996
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia, 1996, Volume: 10, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; Child; Child, Preschool; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Germany; Humans; Incidence; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mercaptopurine; Methotrexate; Molecular Sequence Data; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Transcription, Genetic; Translocation, Genetic; Vincristine	1996
Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia. Leukemia, 1997, Volume: 11 Suppl 3 Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; T-Lymphocytes; Time Factors; Transcription, Genetic; Transplantation Chimera	1997
Effect of conditioned medium, nutritive elements and mitotic synchronization on the accuracy of the cytogenetic analysis in patients with chronic myeloid leukemia at diagnosis and during alpha-interferon therapy. Cancer genetics and cytogenetics, 1999, Volume: 109, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Bone Marrow; Cell Division; Culture Media; Culture Media, Conditioned; Cytogenetics; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Mitotic Index; Tumor Cells, Cultured	1999
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:3 Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome	2000
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia. Leukemia, 2002, Volume: 16, Issue:4 Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2002
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study. Bone marrow transplantation, 1992, Volume: 10, Issue:3 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Pulmonary Fibrosis; Recurrence; Whole-Body Irradiation	1992
Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide. Blood, 1992, May-15, Volume: 79, Issue:10 Topics: Actuarial Analysis; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Whole-Body Irradiation	1992
Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation. Bone marrow transplantation, 1992, Volume: 9, Issue:5 Topics: Adult; Bone Marrow Transplantation; Cyclophosphamide; Dose-Response Relationship, Radiation; Female; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lung; Lung Diseases; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Radiation Protection; Transplantation, Homologous; Whole-Body Irradiation	1992
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. Blood, 1992, Jul-15, Volume: 80, Issue:2 Topics: Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Time Factors	1992
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia. Bone marrow transplantation, 1991, Volume: 7 Suppl 2 Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Italy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy Dosage; Risk Factors; Survival Rate; Whole-Body Irradiation	1991
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia. Bone marrow transplantation, 1991, Volume: 7 Suppl 2 Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Life Tables; Methotrexate; Radiotherapy Dosage; Survival Analysis; Transplantation, Homologous; Washington; Whole-Body Irradiation	1991
Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months. Bone marrow transplantation, 1989, Volume: 4, Issue:6 Topics: Bone Marrow Transplantation; Creatinine; Cyclosporins; Drug Administration Schedule; Graft vs Host Disease; Humans; Kidney Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Randomized Controlled Trials as Topic	1989

Other Studies

63 other study(ies) available for methotrexate and Granulocytic Leukemia, Chronic

Article	Year
Coincidence of lymphomatoid granulomatosis, chronic myelomonocytic leukemia, and anaplastic T cell lymphoma after methotrexate therapy for rheumatoid arthritis. Annals of hematology, 2019, Volume: 98, Issue:2 Topics: Aged; Arthritis, Rheumatoid; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, T-Cell; Lymphomatoid Granulomatosis; Male; Methotrexate; Neoplasms, Second Primary	2019
An atypical isolated CNS blast crisis in chronic myeloid leukaemia. British journal of hospital medicine (London, England : 2005), 2018, Aug-02, Volume: 79, Issue:8 Topics: Aged; Antineoplastic Agents; Blast Crisis; Brain; Central Nervous System Diseases; Cytarabine; Glucocorticoids; Humans; Image Enhancement; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Maintenance Chemotherapy; Male; Methotrexate; Neuroimaging; Spinal Cord; Treatment Outcome	2018
HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia. Cancer, 2014, Feb-01, Volume: 120, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Cyclophosphamide; Cytarabine; Dasatinib; Dexamethasone; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Piperazines; Pyrimidines; Thiazoles; Vincristine	2014
Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease prophylaxis in pediatric hematopoietic stem cell transplantation. Pediatric blood & cancer, 2015, Volume: 62, Issue:2 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome	2015
[Dasatinib-related pneumonia? An example of pharmacovigilance survey]. Revue des maladies respiratoires, 2015, Volume: 32, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cyclophosphamide; Cytarabine; Dasatinib; Dexamethasone; Doxorubicin; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Pharmacovigilance; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Recombinant Proteins; Thiazoles; Tomography, X-Ray Computed; Vincristine	2015
Myelopathy following intrathecal chemotherapy in adults: a single institution experience. Journal of neuro-oncology, 2015, Volume: 122, Issue:2 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Myelin Basic Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spinal Cord; Spinal Cord Diseases	2015
Leukemic glaucoma in a patient with chronic myeloid leukemia treated by intracameral methotrexate. Japanese journal of ophthalmology, 2010, Volume: 54, Issue:4 Topics: Adult; Anterior Chamber; Antimetabolites, Antineoplastic; Aqueous Humor; Glaucoma; Humans; Intraocular Pressure; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Retreatment	2010
Twelfth biannual report of the Cochrane Haematological Malignancies Group--focus on tyrosine kinase inhibitors. Journal of the National Cancer Institute, 2011, Feb-16, Volume: 103, Issue:4 Topics: Adrenal Cortex Hormones; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamide; Dasatinib; Diphosphonates; Disease-Free Survival; Epoetin Alfa; Erythropoietin; Evidence-Based Medicine; Gemtuzumab; Graft vs Host Disease; Hematologic Neoplasms; Hodgkin Disease; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Randomized Controlled Trials as Topic; Recombinant Proteins; Rituximab; Stem Cell Transplantation; Thiazoles; Treatment Outcome; Vidarabine	2011
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia. Leukemia research, 2011, Volume: 35, Issue:10 Topics: Adult; Benzamides; Blast Crisis; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Piperazines; Pyrimidines; Remission Induction; Survival Rate; Transplantation Conditioning; Transplantation, Homologous	2011
[Efficacy of allogeneic hematopoietic stem cell transplantation in treatment of childhood myelogenous leukemia: the observation of 24 cases]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2012, Volume: 50, Issue:11 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2012
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation]. Zhonghua yi xue za zhi, 2002, Apr-25, Volume: 82, Issue:8 Topics: Acute Disease; Adult; Anemia, Aplastic; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Neutrophils; Transplantation, Homologous; Treatment Outcome	2002
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response. British journal of haematology, 2002, Volume: 119, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Humans; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Neoplasm, Residual; Prednisone; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome	2002
Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia. Bone marrow transplantation, 2002, Volume: 30, Issue:11 Topics: Adolescent; Female; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; Humans; Immune Tolerance; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Nuclear Family; Tacrolimus; Transplantation Chimera; Treatment Outcome	2002
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias. Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Hepatitis B; Humans; Imatinib Mesylate; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Salvage Therapy; Vincristine	2003
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation. Bone marrow transplantation, 2003, Volume: 31, Issue:10 Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation	2003
[Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2003, Apr-18, Volume: 35, Issue:2 Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous	2003
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines. International journal of hematology, 2004, Volume: 79, Issue:1 Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Division; Cell Line, Tumor; Cytarabine; Daunorubicin; Diphosphonates; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydroxyurea; Imatinib Mesylate; Imidazoles; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Piperazines; Pyrimidines; Vincristine; Zoledronic Acid	2004
Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy. Leukemia & lymphoma, 2004, Volume: 45, Issue:2 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Blast Crisis; Bone Marrow; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction	2004
Isolated central nervous system blast crisis in chronic myeloid leukemia. Hematological oncology, 2004, Volume: 22, Issue:4 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Bone Marrow; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Humans; Hydrocortisone; Imatinib Mesylate; Injections, Spinal; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Meninges; Methotrexate; Neoplasm Invasiveness; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Remission Induction	2004
[Methotrexate for treatment of graft versus host disease after allogeneic hematopoietic stem cell transplantation]. Zhonghua yi xue za zhi, 2005, Apr-27, Volume: 85, Issue:16 Topics: Adolescent; Adult; Child; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Stem Cell Transplantation	2005
Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation. Bone marrow transplantation, 2006, Volume: 37, Issue:7 Topics: Acute Disease; Adolescent; Adult; Aged; Cohort Studies; Dietary Supplements; Female; Folic Acid; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2006
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Annals of hematology, 2006, Volume: 85, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mercaptopurine; Methotrexate; Middle Aged; Philadelphia Chromosome; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Treatment Outcome	2006
Infliximab in chronic myelogenous leukemia. Leukemia research, 2007, Volume: 31, Issue:3 Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Fusion Proteins, bcr-abl; Humans; Infliximab; Injections, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome	2007
Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report. Journal of neuro-oncology, 2007, Volume: 84, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Blood-Brain Barrier; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Methotrexate; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma, Myeloid; Treatment Outcome	2007
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. American journal of hematology, 2008, Volume: 83, Issue:3 Topics: Acute Disease; Adult; Antineoplastic Agents; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Whole-Body Irradiation	2008
Cobalamin-dependent metabolism in chronic myelogenous leukemia determined by deoxyuridine suppression test and the formiminoglutamic acid and methylmalonate excretion in urine. American journal of hematology, 1995, Volume: 49, Issue:2 Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Cells; Deoxyuridine; Female; Formiminoglutamic Acid; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Malonates; Methotrexate; Middle Aged; Tetrahydrofolates; Thymidine; Tritium; Vitamin B 12	1995
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease. Clinical transplantation, 1994, Volume: 8, Issue:3 Pt 1 Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Risk Factors; Survival Rate	1994
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha. International journal of clinical & laboratory research, 1994, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Cytarabine; Daunorubicin; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Prednisone; Recombinant Proteins; Remission Induction; Vincristine	1994
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Bone marrow transplantation, 1993, Volume: 12, Issue:5 Topics: Adult; Age Factors; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Family Health; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Time Factors; Tissue Donors	1993
High incidence of meningeal leukemia in lymphoid blast crisis of chronic myelogenous leukemia. American journal of hematology, 1993, Volume: 43, Issue:1 Topics: Blast Crisis; HLA-DR Antigens; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Meninges; Methotrexate; Neprilysin; Radiotherapy; Survival Analysis; Time Factors	1993
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease. European journal of haematology, 1993, Volume: 50, Issue:5 Topics: Adolescent; Adult; Bone Marrow Cells; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Retrospective Studies	1993
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia. Acta haematologica, 1993, Volume: 89, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Daunorubicin; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Recurrence; Remission Induction; Time Factors; Transplantation, Homologous; Vincristine	1993
Orbito-ocular granulocytic sarcoma (OOGS) and acute myeloblastic leukemia (AML) with duplication of Philadelphia chromosome. Cancer genetics and cytogenetics, 1993, Volume: 69, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Eye Neoplasms; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Multigene Family; Neoplasms, Multiple Primary; Orbital Neoplasms; Philadelphia Chromosome; Thioguanine	1993
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies. Blood, 1993, Feb-01, Volume: 81, Issue:3 Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors	1993
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood, 1993, Feb-15, Volume: 81, Issue:4 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1993
Expression of rTS correlates with altered growth regulation of thymidylate synthase. Cancer research, 1996, Feb-15, Volume: 56, Issue:4 Topics: Blotting, Northern; Cell Division; Cell Line; DNA, Antisense; Drug Resistance, Neoplasm; Gene Expression; Humans; KB Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Molecular Sequence Data; Open Reading Frames; Protein Biosynthesis; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Tumor Cells, Cultured	1996
[Separation of methotrexate-polyglutamates by capillary electrophoresis and its application to the measurement of gamma-glutamyl hydrolase activity in human leukemia cells in culture]. Rinsho byori. The Japanese journal of clinical pathology, 1996, Volume: 44, Issue:1 Topics: Down-Regulation; Electrophoresis, Capillary; gamma-Glutamyl Hydrolase; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Polyglutamic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reproducibility of Results; Tumor Cells, Cultured	1996
Temporal association between the use of methotrexate and development of leukemia in 2 patients with rheumatoid arthritis. The Journal of rheumatology, 1995, Volume: 22, Issue:12 Topics: Arthritis, Rheumatoid; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Time Factors	1995
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood, 1997, Jun-15, Volume: 89, Issue:12 Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Blast Crisis; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Idarubicin; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lupus Erythematosus, Systemic; Methotrexate; Prednisone; Remission Induction; Transplantation, Autologous; Vincristine	1997
Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo. Blood, 1997, Dec-15, Volume: 90, Issue:12 Topics: Animals; Antimetabolites, Antineoplastic; Cell Line; Fusion Proteins, bcr-abl; Genetic Therapy; Genetic Vectors; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Mice; Mice, Inbred C3H; Neoplastic Stem Cells; Retroviridae; RNA, Messenger; Tetrahydrofolate Dehydrogenase	1997
Linear chronic cutaneous graft-versus-host disease. Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:6 Topics: Adult; Basement Membrane; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Cytarabine; E-Selectin; Epidermis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Keratosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Methotrexate; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Homologous; Whole-Body Irradiation	1997
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase. Bone marrow transplantation, 1997, Volume: 20, Issue:11 Topics: Adult; Bone Marrow Cells; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Flow Cytometry; Graft Rejection; Graft vs Host Disease; Humans; Immunoglobulins, Intravenous; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Pilot Projects; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous	1997
Variable expression of RFC1 in human leukemia cell lines resistant to antifolates. Cancer letters, 1998, Feb-27, Volume: 124, Issue:2 Topics: Antimetabolites, Antineoplastic; Biological Transport; Carrier Proteins; Drug Resistance, Neoplasm; Folic Acid; Folic Acid Antagonists; Humans; Leucovorin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; Tetrahydrofolate Dehydrogenase; Thiophenes; Tumor Cells, Cultured	1998
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:2 Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus	1998
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients. Bone marrow transplantation, 1999, Volume: 24, Issue:9 Topics: Adult; Antimetabolites, Antineoplastic; Hematoma, Subdural; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Risk Factors; Spinal Puncture; Tomography, X-Ray Computed	1999
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry. Blood, 2000, Jan-15, Volume: 95, Issue:2 Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Multivariate Analysis; Nuclear Family; Registries; Survival Analysis; Transplantation, Homologous	2000
In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents. Blood, 2001, Apr-01, Volume: 97, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cytarabine; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Harringtonines; Homoharringtonine; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Microbial Sensitivity Tests; Neoplasm Proteins; Neoplasms; Piperazines; Pyrimidines; Tumor Cells, Cultured; Vincristine	2001
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis. British journal of haematology, 2001, Volume: 113, Issue:1 Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous	2001
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood, 2001, Jul-01, Volume: 98, Issue:1 Topics: Adult; Bilirubin; Biotransformation; Bone Marrow Transplantation; Cohort Studies; Female; Genotype; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mouth Mucosa; Oxidoreductases Acting on CH-NH Group Donors; Platelet Count; Point Mutation; Polymorphism, Genetic; Stomatitis	2001
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient. Bone marrow transplantation, 2001, Volume: 28, Issue:8 Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation	2001
Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:3 Topics: Animals; Bone Marrow Transplantation; Cell Survival; Disease Progression; Drug Resistance, Neoplasm; Flow Cytometry; Folic Acid Antagonists; Hematocrit; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Mice; Mice, Inbred C3H; Organ Size; Survival Analysis; Tetrahydrofolate Dehydrogenase; Tumor Cells, Cultured	2002
Cytomegalovirus infection in children with blood diseases. Acta haematologica Polonica, 1992, Volume: 23, Issue:3 Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Daunorubicin; Female; gamma-Globulins; Humans; Immune Tolerance; Immunization, Passive; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Thioguanine; Vincristine	1992
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome. British journal of haematology, 1992, Volume: 81, Issue:3 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; DNA, Neoplasm; Drug Therapy, Combination; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; RNA, Messenger; Transcription, Genetic	1992
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood, 1992, Nov-15, Volume: 80, Issue:10 Topics: Adolescent; Adult; Aged; Bacteria, Anaerobic; Bone Marrow Transplantation; Child; Cyclosporine; Family; Female; Graft vs Host Disease; Humans; Intestines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Tissue Donors	1992
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. American journal of hematology, 1991, Volume: 36, Issue:4 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomycin; Body Height; Body Weight; Child; Child Development; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulins; Intelligence; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Sex Characteristics; Vinblastine; Vincristine	1991
Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro. Anti-cancer drug design, 1991, Volume: 6, Issue:5 Topics: Animals; Bleomycin; Drug Synergism; Etoposide; Humans; Indomethacin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Lung Neoplasms; Lymphoma; Methotrexate; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostaglandins; Protein Kinase Inhibitors; Tumor Cells, Cultured	1991
[The analysis of leukemic relapse after allogeneic bone marrow transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1991, Volume: 32, Issue:11 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Homologous	1991
Several new approaches to improvement of alpha interferon therapy in chronic myelogenous leukaemia. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27 Suppl 4 Topics: Animals; Combined Modality Therapy; Genetic Therapy; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Mice; RNA, Messenger; RNA, Neoplasm	1991
Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group. Cancer research, 1990, Mar-15, Volume: 50, Issue:6 Topics: Aminopterin; Animals; Biological Transport; Cell Division; Folic Acid Antagonists; gamma-Glutamyl Hydrolase; Humans; Leucovorin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rats; Structure-Activity Relationship; Tumor Cells, Cultured	1990
Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases. Blood, 1990, Apr-15, Volume: 75, Issue:8 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Drug Combinations; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prognosis; Recurrence; Transplantation, Homologous	1990
Impairment of methotrexate (MTX)-polyglutamate formation of MTX-resistant K562 cell lines. Japanese journal of cancer research : Gann, 1988, Volume: 79, Issue:11 Topics: Drug Resistance; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Peptide Biosynthesis; Polyglutamic Acid; Purines; Tumor Cells, Cultured	1988
Sensitivity to purine analogues in childhood leukemia assessed by the automated MTT-assay. Advances in experimental medicine and biology, 1989, Volume: 253A Topics: Child; Coloring Agents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purines; Thioguanine	1989
[Transplantation of bone marrow from unrelated donors in chronic myeloid leukemia]. Deutsche medizinische Wochenschrift (1946), 1989, Jun-23, Volume: 114, Issue:25 Topics: Bone Marrow Transplantation; Chronic Disease; Cyclophosphamide; Cyclosporins; Drug Therapy, Combination; Etoposide; Graft vs Host Reaction; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Tissue Donors; Whole-Body Irradiation	1989